Francois Dabis

Summary

Country: France

Publications

  1. pmc Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a clus
    Collins C Iwuji
    Africa Centre for Health and Population Studies, University of KwaZulu Natal, Somkhele, KwaZulu Natal, South Africa
    Trials 14:230. 2013
  2. pmc Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
    Alexandra Calmy
    HIV Unit, Geneva University Hospital, Geneva, Switzerland
    BMC Infect Dis 12:147. 2012
  3. pmc Cervical cancer screening by visual inspection in Côte d'Ivoire, operational and clinical aspects according to HIV status
    Apollinaire Horo
    Service de Gynecologie Obstetrique, Centre Hospitalier Universitaire de Yopougon, Abidjan, Cote d Ivoire, France
    BMC Public Health 12:237. 2012
  4. ncbi request reprint Children and HIV in Africa: what is next?
    Francois Dabis
    INSERM U593, Institut de Santé Publique, Epidémiologie et Développement, Universite Victor Segalen, 33076 Cedex, Bordeaux, France
    Lancet 362:1597-8. 2003
  5. pmc Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission
    Francois Dabis
    Unité INSERM 593, Institut de Santé Publique, Epidémiologie et Développement ISPED, Universite Victor Segalen, 146 rue Leo Saignat, 33076 Bordeaux, France
    AIDS 19:309-18. 2005
  6. ncbi request reprint 18-Month mortality and perinatal exposure to zidovudine in West Africa
    F Dabis
    Unité INSERM no 330, ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    AIDS 15:771-9. 2001
  7. ncbi request reprint Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts
    Francois Dabis
    INSERM U 593, ISPED, Universite Victor Segalen, Bordeaux Cedex, France
    Int J Epidemiol 34:979-86. 2005
  8. pmc Improving child health: the role of research
    F Dabis
    Institut de Santé Publique, d Épidémiologie et de Développement, Case 11, Universite Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex, France
    BMJ 324:1444-7. 2002
  9. pmc Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire
    Henriette A Vanga-Bosson
    Programme PAC CI, Abidjan, Cote d Ivoire
    Malar J 10:105. 2011
  10. pmc Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire
    Patrick A Coffie
    Programme MTCT Plus, ACONDA, BP 1954 Abidjan 18, Abidjan, Cote d Ivoire
    BMC Infect Dis 10:188. 2010

Research Grants

Detail Information

Publications118 found, 100 shown here

  1. pmc Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a clus
    Collins C Iwuji
    Africa Centre for Health and Population Studies, University of KwaZulu Natal, Somkhele, KwaZulu Natal, South Africa
    Trials 14:230. 2013
    ..The first phase will specifically focus on the trial's secondary outcomes...
  2. pmc Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
    Alexandra Calmy
    HIV Unit, Geneva University Hospital, Geneva, Switzerland
    BMC Infect Dis 12:147. 2012
    ..We assessed the impact of on-going HIV-RNA replication on CD4 cell count slopes in patients treated with a first-line combination ART...
  3. pmc Cervical cancer screening by visual inspection in Côte d'Ivoire, operational and clinical aspects according to HIV status
    Apollinaire Horo
    Service de Gynecologie Obstetrique, Centre Hospitalier Universitaire de Yopougon, Abidjan, Cote d Ivoire, France
    BMC Public Health 12:237. 2012
    ..Cervical cancer screening is not yet standard of care of women attending HIV care clinics in Africa and presents operational challenges that need to be addressed...
  4. ncbi request reprint Children and HIV in Africa: what is next?
    Francois Dabis
    INSERM U593, Institut de Santé Publique, Epidémiologie et Développement, Universite Victor Segalen, 33076 Cedex, Bordeaux, France
    Lancet 362:1597-8. 2003
  5. pmc Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission
    Francois Dabis
    Unité INSERM 593, Institut de Santé Publique, Epidémiologie et Développement ISPED, Universite Victor Segalen, 146 rue Leo Saignat, 33076 Bordeaux, France
    AIDS 19:309-18. 2005
    ..We evaluated the 6-week field efficacy of two more PMTCT drug combinations...
  6. ncbi request reprint 18-Month mortality and perinatal exposure to zidovudine in West Africa
    F Dabis
    Unité INSERM no 330, ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    AIDS 15:771-9. 2001
    ..To study mortality in African children born to HIV-1-infected mothers exposed peripartum to zidovudine...
  7. ncbi request reprint Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts
    Francois Dabis
    INSERM U 593, ISPED, Universite Victor Segalen, Bordeaux Cedex, France
    Int J Epidemiol 34:979-86. 2005
  8. pmc Improving child health: the role of research
    F Dabis
    Institut de Santé Publique, d Épidémiologie et de Développement, Case 11, Universite Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex, France
    BMJ 324:1444-7. 2002
  9. pmc Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire
    Henriette A Vanga-Bosson
    Programme PAC CI, Abidjan, Cote d Ivoire
    Malar J 10:105. 2011
    ..Data on IPT-SP coverage and factors associated with placental malaria parasitaemia and low birth weight (LBW) are scarce in Côte d'Ivoire...
  10. pmc Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire
    Patrick A Coffie
    Programme MTCT Plus, ACONDA, BP 1954 Abidjan 18, Abidjan, Cote d Ivoire
    BMC Infect Dis 10:188. 2010
    ..We estimated the incidence of SAEs according to CD4 cell count and identify their risk factors in nevirapine-treated women...
  11. pmc Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'Ivoire
    Renaud Becquet
    Institut National de la Santé et de la Recherche Médicale Unité 593, Universite Victor Segalen, Bordeaux, France
    PLoS Med 4:e17. 2007
    ..Little is known about the long-term safety of infant feeding interventions aimed at reducing breast milk HIV transmission in Africa...
  12. ncbi request reprint Virological response to HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors-based, tenofovir DF-including regimens in the ANRS Aquitaine Cohort
    Eric Balestre
    INSERM U593, Universite Victor Segalen, Bordeaux, France
    J Clin Virol 36:95-9. 2006
    ..We wished to investigate the virological response to these regimens in a large cohort of antiretroviral (ARV)-treated patients...
  13. pmc 18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission
    Valeriane Leroy
    French National Institute for Health and Medical Research INSERM, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France
    PLoS ONE 3:e1645. 2008
    ..We assessed the 18-month effectiveness of short-course (sc) antiretroviral peripartum regimens combined with alternatives to prolonged breastfeeding to prevent mother-to-child transmission (MTCT) of HIV-1 in Abidjan, Côte d'Ivoire...
  14. doi request reprint Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy
    Olivia Peuchant
    Virology Laboratory, Bordeaux University Hospital, Bordeaux, France
    AIDS 22:1417-23. 2008
    ..We investigated the clinical relevance of the detection of majority and minority-resistant variants in an observational study in antiretroviral therapy naive, recently infected patients...
  15. doi request reprint HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008
    Mathias Bruyand
    Inserm U 897, Bordeaux School of Public Health ISPED, Université Bordeaux Segalen, Bordeaux, France
    J Hepatol 55:1058-62. 2011
    ..We aimed at estimating the relationship between the occurrence of hepatocarcinoma and both types of measures of immunodeficiency, current and cumulative (time below a given threshold), to assess their independent effects...
  16. doi request reprint Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006
    Patrick A Coffie
    Unité Institut National de Santé et de Rechereche Médicale 593, Bordeaux, France
    Clin Infect Dis 46:611-21. 2008
    ....
  17. ncbi request reprint Acceptability of formula-feeding to prevent HIV postnatal transmission, Abidjan, Côte d'Ivoire: ANRS 1201/1202 Ditrame Plus Study
    Valeriane Leroy
    INSERM, 593 Institut de Santé Publique, Epidémiologie et Développement ISPED, Universite Victor Segalen, Bordeaux, France
    J Acquir Immune Defic Syndr 44:77-86. 2007
    ..To describe the maternal acceptability of formula-feeding proposed to reduce postnatal HIV transmission in Abidjan, Côte d'Ivoire...
  18. ncbi request reprint Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa
    Valeriane Leroy
    Unité INSERM n degrees 593, Universite Victor Segalen, Bordeaux, France
    AIDS 17:1493-501. 2003
    ..To assess the postnatal transmission (PT) risk of HIV-1 after a maternal short-course zidovudine regimen in a breastfeeding population...
  19. pmc Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007
    Antoine Benard
    INSERM, U897, CIC EC7, Bordeaux, France
    PLoS ONE 5:e8896. 2010
    ..Our objective was to estimate the effect of tobacco smoking withdrawal on the risk of bacterial pneumonia among HIV-infected individuals...
  20. ncbi request reprint Avascular necrosis in HIV-infected patients: a case-control study from the Aquitaine Cohort, 1997-2002, France
    Sylvie Lawson-Ayayi
    Institut National de la Santé et de la Recherche Médicale Unité 593, Centre d information et de soins de l immunodeficience humaine, Bordeaux, France
    Clin Infect Dis 40:1188-93. 2005
    ..A conditional logistic regression model showed that current alcohol consumption and a history of steroid use were the only factors associated with the occurrence of AN...
  21. ncbi request reprint Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?
    Corinne Rancinan
    INSERM Unité 330, 146 rue Leo Saignat, 33076 Bordeaux, France
    AIDS 16:1357-62. 2002
    ..To study whether hepatitis C virus (HCV) co-infection or the severe elevation of transaminases is associated with survival after the initiation of antiretroviral combination therapy...
  22. ncbi request reprint Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001
    Rodolphe Thiebaut
    Institut National de la Santé et de la Recherche Médicale Unité 330, Institut de Santé Publique, d Épidémiologie et de Développement, Universite Victor Segalen, Bordeaux, France
    J Acquir Immune Defic Syndr 33:380-6. 2003
    ..Clinical decisions and interpretation of clinical trial results must weigh the signification of each of these 2 biomarkers...
  23. pmc Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings
    Renaud Becquet
    INSERM, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France
    Clin Infect Dis 49:1936-45. 2009
    ..On the basis of available evidence, we suggest translating into practice the recently available evidence on this matter without any further delay...
  24. pmc Complementary feeding adequacy in relation to nutritional status among early weaned breastfed children who are born to HIV-infected mothers: ANRS 1201/1202 Ditrame Plus, Abidjan, Cote d'Ivoire
    Renaud Becquet
    Unité INSERM 593, Institut de Santé Publique Epidémiologie et Développement, Universite Victor Segalen, Bordeaux, France
    Pediatrics 117:e701-10. 2006
    ....
  25. ncbi request reprint Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France
    Fabrice Bonnet
    Service de Medecine Interne et Maladies Infectieuses, Hôpital Saint André, Bordeaux, France
    Clin Infect Dis 42:411-7. 2006
    ....
  26. pmc Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort
    Linda Wittkop
    INSERM, Unit Epidemiology and Biostatistics, Bordeaux, France
    J Antimicrob Chemother 63:1251-5. 2009
    ..We studied viro-immunological response, pharmacokinetic parameters and genotypic test results in an observational cohort of multiple ARV class-experienced patients starting a raltegravir-based regimen...
  27. ncbi request reprint Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis
    Elise Arrive
    Unité INSERM 593, Bordeaux, France
    Int J Epidemiol 36:1009-21. 2007
    ..This systematic review and meta-analysis of summarized data aimed to estimate the proportion of mothers and children with NVP resistance mutations detected in plasma samples 4-8 weeks postpartum after single-dose NVP use for PMTCT...
  28. ncbi request reprint Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings
    Didier K Ekouevi
    Programme PACCI, Abidjan, Cote d Ivoire, INSERM, Unité 593, Bordeaux, France
    AIDS Res Hum Retroviruses 23:1469-74. 2007
    ..To accurately target the most appropriate time to start HAART, the CD4 percentage could be more reliable than the absolute count in sub-Saharan African pregnant women...
  29. ncbi request reprint Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?
    Valeriane Leroy
    INSERM U 593, Institut d Epidémiologie, Santé Publique et Développement ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    AIDS 19:1865-75. 2005
    ....
  30. ncbi request reprint Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort
    Didier Neau
    Fédération des Maladies Infectieuses et Tropicales, Centre Hospitalo Universitaire, Hopital Pellegrin, Bordeaux, France
    J Acquir Immune Defic Syndr 45:168-73. 2007
    ..The prevalence and factors associated with hepatic steatosis are not well defined in HCV-HIV-coinfected patients...
  31. ncbi request reprint Change in atherosclerosis progression in HIV-infected patients: ANRS Aquitaine Cohort, 1999-2004
    Rodolphe Thiebaut
    INSERM EMI 0338, ISPED, Universite Victor Segalen Bordeaux 2, 33076 Bordeaux, France
    AIDS 19:729-31. 2005
    ..The progression of atherosclerosis in HIV-infected patients can be controlled. The impact of individual measures to reduce the cardiovascular risk should be evaluated further...
  32. pmc 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study
    Jérôme Harambat
    INSERM, Unité 897, Bordeaux, France
    BMC Public Health 8:169. 2008
    ....
  33. pmc Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapy
    Linda Wittkop
    INSERM, Unit 897, Bordeaux, France
    BMC Med Res Methodol 8:68. 2008
    ..Without pre-selection each mutation presented in at least one patient is considered with a different weight. We compared these two strategies with the construction of a usual genotypic score...
  34. pmc Interpretation of genotype and pharmacokinetics for resistance to fosamprenavir-ritonavir-based regimens in antiretroviral-experienced patients
    Isabelle Pellegrin
    Department of Virology, INSERM U593, Bordeaux University Hospital, France
    Antimicrob Agents Chemother 51:1473-80. 2007
    ..Specific mutations, PK and GIQ, provide relevant information for monitoring fosamprenavir-ritonavir-based HAART...
  35. pmc Knowledge, attitudes, and beliefs of health care workers regarding alternatives to prolonged breast-feeding (ANRS 1201/1202, Ditrame Plus, Abidjan, Côte d'Ivoire)
    Renaud Becquet
    Unité INSERM 593, Institut de Santé Publique Epidémiologie Développement, Universite Victor Segalen, Bordeaux, France
    J Acquir Immune Defic Syndr 40:102-5. 2005
    ..However, proposing alternatives to prolonged breast-feeding causes difficulties for health care workers that should be taken into account when tailoring such complex interventions...
  36. doi request reprint Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort
    Linda Wittkop
    University Bordeaux, ISPED, Centre INSERM U897 Epidemiologie Biostatistique, France
    J Infect Dis 207:622-7. 2013
    ..Therefore, the CMV-induced immune response seems to be associated with chronic immune activation in cART recipients with sustained virological suppression...
  37. doi request reprint Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?
    Pascale Trimoulet
    Laboratoire de Microbiologie Fondamentale et Pathogénicité UMR 5234, Centre Hospitalier Universitaire CHU et Université Bordeaux Ségalen, Hopital Pellegrin, Bordeaux, France
    J Virol Methods 181:131-3. 2012
    ..0001). This study shows that using the same assay in multicenter trials and cohorts is still relevant due to inter-assay differences observed in HCV plasma load measurements...
  38. pmc Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa
    Didier K Ekouevi
    INSERM, U897, and ISPED, Universite Bordeaux 2, Bordeaux, France
    Trop Med Int Health 15:34-42. 2010
    ..To study factors associated with the probability of retention in antiretroviral therapy (ART) programmes in West Africa...
  39. ncbi request reprint Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa?
    Charlotte Sakarovitch
    INSERM EMI 03 38, Institut de Santé Publique, Epidemiologie, et Développement ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    J Acquir Immune Defic Syndr 45:115-22. 2007
    ..The authors conclude that none of the 4 methods could currently be used to estimate HIV-1 incidence routinely in Côte d'Ivoire but that further adaptations might enhance their accuracy...
  40. pmc Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast
    Didier Koumavi Ekouevi
    Unité Institut National de la Santé et de la Recherche Médicale 593, Institut de Santé Publique, Epidémiologie et Développement, Universite Victor Segalen, Bordeaux, France
    Pediatrics 118:e1071-7. 2006
    ..We measured the serum lactate levels in children born to HIV-1 infected African women receiving short-term antiretroviral prevention of mother-to-child transmission of HIV regimens...
  41. doi request reprint Early mixed feeding and breastfeeding beyond 6 months increase the risk of postnatal HIV transmission: ANRS 1201/1202 Ditrame Plus, Abidjan, Côte d'Ivoire
    Renaud Becquet
    INSERM, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France
    Prev Med 47:27-33. 2008
    ..To evaluate the risk of postnatal HIV transmission among women in Abidjan, Côte d'Ivoire offered alternatives to prolonged breastfeeding, and to assess the impact of the breastfeeding pattern and duration on this risk...
  42. pmc Acceptability of exclusive breast-feeding with early cessation to prevent HIV transmission through breast milk, ANRS 1201/1202 Ditrame Plus, Abidjan, Côte d'Ivoire
    Renaud Becquet
    Unité INSERM 593, Institut de Santé Publique Epidémiologie Développement ISPE, Universite Victor Segalen, Bordeaux, France
    J Acquir Immune Defic Syndr 40:600-8. 2005
    ..We assessed the uptake of a nutritional intervention promoting exclusive breast-feeding with early cessation between 3 and 4 months of age to reduce postnatal transmission of HIV in Abidjan, Côte d'Ivoire...
  43. doi request reprint Increasing HIV testing among male partners
    Joanna Orne-Gliemann
    INSERM, Centre Inserm U897 Épidémiologie et Biostatistique, Université Bordeaux Segalen, Bordeaux, France
    AIDS 27:1167-77. 2013
    ..We conducted a randomized trial of the efficacy of COC on partner HIV testing in low/medium HIV prevalence settings (Cameroon, Dominican Republic, Georgia, India)...
  44. doi request reprint Chronic viral hepatitis is associated with low bone mineral density in HIV-infected patients, ANRS CO 3 Aquitaine Cohort
    Sylvie Lawson-Ayayi
    INSERM Unité 897, Université Bordeaux Segalen, Bordeaux, France Institut de Santé Publique, Epidémiologie et Développement ISPED, Université Bordeaux Segalen, Bordeaux, France COREVIH d Aquitaine, Centre Hospitalier Universitaire CHU de Bordeaux, Bordeaux, France Services des Maladies Infectieuses et Médecine Tropicale, Hopital Pellegrin, CHU de Bordeaux, Bordeaux, France Service d Imagerie Médicale, CHU de Bordeaux, Bordeaux, France Service de Rhumatologie, CHU de Bordeaux, Bordeaux, France and Service de Médecine Interne et de Maladies Infectieuses, Hôpital Saint André, CHU de Bordeaux, Bordeaux, France See the Appendix for details
    J Acquir Immune Defic Syndr 62:430-5. 2013
    ..High prevalence rates of low bone mineral density (BMD) have been reported in people living with HIV infection. We aimed to investigate the association of chronic viral hepatitis with low BMD in HIV-infected patients...
  45. doi request reprint Reduced bone mineral density in HIV-infected patients: prevalence and associated factors
    Charles Cazanave
    Fédération de maladies infectieuses et tropicales, Hopital Pellegrin, Place A, Raba Léon, 33076 Bordeaux Cedex, France
    AIDS 22:395-402. 2008
    ..There is a high prevalence of bone demineralization among HIV-infected patients but mechanisms of alteration of bone turnover are still unclear and it is thought to be multifactorial...
  46. pmc Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection
    Estibaliz Lazaro
    Department of Internal Medicine and Infectious Diseases, Bordeaux University Hospital, Bordeaux, France
    Antivir Ther 11:343-50. 2006
    ..To compare changes in CD4+, CD8+ and total lymphocyte counts after initiation of highly active antiretroviral therapy (HAART) between HIV-infected patients with and without a recent history of Mycobacterium avium complex (MAC) infection...
  47. ncbi request reprint [A decade of child health research in developing countries]
    Joanna Orne-Gliemann
    Institut de Santé Publique, d Épidémiologie et de Développement, Universite Victor Segalen Bordeaux 2, Case 11, 33086 Bordeaux, France
    Sante 13:69-75. 2003
    ..Furthermore, it appears that descriptive epidemiology, evaluation and priority setting strategies are essential tools to guide adequate research activities and further improvement of child health...
  48. doi request reprint Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort
    Marc Arthur Loko
    Universite Bordeaux, ISPED, Centre INSERM U897 Epidemiologie Biostatistique, F 33000 Bordeaux, France
    Antivir Ther 17:1335-43. 2012
    ..The aim of this study was to describe changes in repeated liver stiffness (LS) measurements and to assess the determinants of increase in LS in HIV-HCV-coinfected patients...
  49. ncbi request reprint HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity
    Patricia Recordon-Pinson
    CHU de Bordeaux, Laboratoire de Virologie, and Université Victor Segalen Bordeaux 2, Bordeaux, France
    Antivir Ther 14:551-6. 2009
    ..We investigated the relationship between the dynamics of HIV-1 transmission within recently infected patients, the HIV-1 variability and the transmission of antiretroviral drug resistance...
  50. pmc The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010
    Marc Arthur Loko
    INSERM, U897 and ISPED, Universite Victor Segalen, Bordeaux, France
    BMC Infect Dis 10:303. 2010
    ..The ANRS CO 13 HEPAVIH cohort was set up to explore these critical questions.To describe the cohort aims and organization, monitoring and data collection procedures, baseline characteristics, as well as follow-up findings to date...
  51. ncbi request reprint Acceptability of routine HIV testing ("opt-out") in antenatal services in two rural districts of Zimbabwe
    Freddy Perez
    Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen, Bordeaux 2, France
    J Acquir Immune Defic Syndr 41:514-20. 2006
    ..Issues regarding, stigma, quality of post-testing counseling and staffing must be considered, however...
  52. doi request reprint Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy
    Frédéric Antoine Dauchy
    Services de Maladies Infectieuses et Tropicales and COREVIH, Hopital Pellegrin, CHU de Bordeaux, Université Bordeaux Segalen, Bordeaux, France
    Kidney Int 80:302-9. 2011
    ..22) or had been discontinued (OR 11.49). Thus, cumulative exposure to TDF and/or atazanavir was associated with an increased risk of PRTD, with concern about its reversibility in patients with HIV...
  53. doi request reprint Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults
    Christine Danel
    INSERM, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France
    J Infect Dis 199:66-76. 2009
    ..A randomized trial was launched in Côte d'Ivoire in 2002 to compare continuous antiretroviral treatment (hereafter, "C-ART") to an ART regimen of 2 months off and 4 months on therapy (hereafter, "2/4-ART"). We report the final analysis...
  54. ncbi request reprint Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration
    Elise Arrive
    Unité INSERM 593, Institut de Santé Publique, Epidémiologie et Développement ISPED, Universite Victor Segalen, Bordeaux, France
    Int J Epidemiol 37:474-80. 2008
  55. ncbi request reprint HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population
    Charlotte Lewden
    INSERM, U593, Bordeaux, France
    J Acquir Immune Defic Syndr 46:72-7. 2007
    ..To compare mortality rates in combination antiretroviral therapy (cART)-treated HIV-infected adults with mortality in the general population according to the level of CD4 cell count reached and the duration of exposure to cART...
  56. pmc Health care resource utilization in untreated HIV-infected children in a pediatric programme, Abidjan, Côte d'Ivoire, 2004-2009
    Sophie Desmonde
    Centre INSERM, U897 Epidémiologie Biostatistiques, Bordeaux, France
    J Acquir Immune Defic Syndr 62:e14-21. 2013
    ..We describe health care resource utilization among HIV-1-infected children who have not yet undergone antiretroviral treatment (ART) in Abidjan, Côte d'Ivoire...
  57. pmc Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa
    Eric Balestre
    Universite Bordeaux, ISPED, Centre INSERM U Epidemiologie Biostatistique, France
    AIDS 26:951-7. 2012
    ..To assess the effect of aging on the immunological response to antiretroviral therapy (ART) in the West African context...
  58. pmc Prevention of mother to child transmission of HIV: evaluation of a pilot programme in a district hospital in rural Zimbabwe
    Freddy Perez
    Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat, 33076 Bordeaux, France
    BMJ 329:1147-50. 2004
    ..Zimbabwe has one of the highest rates of HIV seroprevalence in the world. In 2001 only 4% of women and children in need of services for prevention of mother to child transmission of HIV were receiving them...
  59. doi request reprint Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance
    Elise Arrive
    INSERM U897, Universite Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex, France
    AIDS 24:2481-8. 2010
    ..We aimed to evaluate the tolerance and resistance profiles of a combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) given to HIV-1-infected delivering women and their newborns...
  60. ncbi request reprint Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002
    F Bonnet
    Department of Internal Medicine and Infectious Diseases, Saint Andre Hospital, Bordeaux University Hospital, Bordeaux, France
    HIV Med 6:198-205. 2005
    ..To determine the factors associated with clinical progression (AIDS events and death) in antiretroviral-naive patients who have begun highly active antiretroviral therapy (HAART)...
  61. doi request reprint CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007
    Mathias Bruyand
    INSERM U 897 Epidemiology and Biostatistics, Bordeaux, France
    J Clin Virol 50:177-80. 2011
    ..CMV reactivation, which enhances immune senescence, could be associated with a higher risk of cancer...
  62. pmc Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis
    Renaud Becquet
    Institut National de la Sante et de la Recherche Medicale, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France
    PLoS ONE 7:e28510. 2012
    ..Improved estimates of infant survival by timing of HIV-infection (perinatally or postnatally) are thus needed...
  63. ncbi request reprint Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial
    V Leroy
    INSERM U330, ISPED, , Bordeaux, France
    AIDS 15:517-22. 2001
    ..CONCLUSION: High maternal viral load at inclusion strongly predicts MTCT of HIV in Africa. A short ZDV treatment regimen decreases significantly maternal viral load from its pretreatment level...
  64. ncbi request reprint Dual nucleoside regimens in nonadvanced HIV infection: prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)
    P Morlat
    Service de Medecine Interne et Maladies Infectieuses, Hôpital Saint André, Centre Hospitalier Universitaire, Bordeaux, France
    J Acquir Immune Defic Syndr 23:255-60. 2000
    ....
  65. doi request reprint Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort
    Marc Arthur Loko
    INSERM, U593, Bordeaux, France
    Am J Gastroenterol 103:1973-80. 2008
    ..Although an increasing number of noninvasive fibrosis markers are available in HCV-monoinfected patients, data on the performance of these tests in HIV-HCV-coinfected patients are lacking...
  66. pmc Infant feeding practices before implementing alternatives to prolonged breastfeeding to reduce HIV transmission through breastmilk in Abidjan, Cote d'Ivoire
    Renaud Becquet
    Unité INSERM 593, Institut de Santé Publique Epidémiologie Développement, Universite Victor Segalen, Bordeaux, France
    J Trop Pediatr 51:351-5. 2005
    ..This study provides useful information for planning purposes in this urban African population, where exclusive breastfeeding is rare and the use of infant formula relatively common...
  67. ncbi request reprint Risk factors for hyperlactataemia in HIV-infected patients, Aquitaine Cohort, 1999--2003
    Fabrice Bonnet
    Service de Medecine Interne et Maladies Infectieuses, Hôpital Saint André, Bordeaux, France
    Antivir Chem Chemother 16:63-7. 2005
    ..It could be proposed that patients having one or more of these risk factors undergo regular monitoring of plasma lactate and renal function to prevent lactic acidosis...
  68. ncbi request reprint Pravastatin in HIV-infected patients treated with protease inhibitors: a placebo-controlled randomized study
    Fabrice Bonnet
    Service de Medecine Interne et Maladies Infectieuses, Hôpital Saint André, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
    HIV Clin Trials 8:53-60. 2007
    ..5 mmol/L...
  69. ncbi request reprint Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997
    E Malvy
    Unité INSERM 330, Universite Victor Segalen Bordeaux 2, Hĵpital Saint André, Centre Hospitalier Universitaire de Bordeaux, France
    J Am Coll Nutr 20:609-15. 2001
    ..To assess the performance of weight related nutritional markers (reported involuntary weight loss greater than 10%, measured weight loss and body mass index-BMI-) in predicting HIV disease progression...
  70. ncbi request reprint Estimating the efficacy of interventions to prevent mother-to-child transmission of human immunodeficiency virus in breastfeeding populations: comparing statistical methods
    Ahmadou Alioum
    INSERM U 593, Institut d Epidémiologie, Santé Publique et Développement, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    Am J Epidemiol 158:596-605. 2003
    ..For estimation of this proportion at age 18 months, more sophisticated methods, such as the extension of the Kaplan-Meier procedure to interval-censored data and competing risks, would be preferred...
  71. ncbi request reprint Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa
    Valeriane Leroy
    Unité INSERM 330, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat, 33076 Bordeaux Cedex, France
    AIDS 16:631-41. 2002
    ..To assess the 24 month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission (MTCT) of HIV-1 in a breastfeeding population in West Africa...
  72. ncbi request reprint Virological characterization of an infection with a dual-tropic, multidrug-resistant HIV-1 and further evolution on antiretroviral therapy
    Bernard Masquelier
    Department of Virologie et Immunologie Biologique, CHU de Bordeaux, Bordeaux, France
    AIDS 21:103-6. 2007
    ..ART, even if suboptimal, can be of interest in the case of MDR virus infection...
  73. pmc Pharmacovigilance for antiretroviral drugs in Africa: lessons from a study in Abidjan, Cote d'Ivoire
    Antoine Jaquet
    INSERM CRE U 897, Institute of Public Health and Development, Universite Victor Segalen, Bordeaux, France
    Pharmacoepidemiol Drug Saf 20:1303-10. 2011
    ..We assessed knowledge towards pharmacovigilance among ART prescribers and available capacity of HIV clinics to conduct ADR monitoring in Abidjan, Côte d'Ivoire...
  74. pmc Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009
    Sophie Desmonde
    INSERM, U897 and Institut de Santé Publique, Epidémiologie et Développement ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    BMC Infect Dis 11:182. 2011
    ..Clinical evolution of HIV-infected children who have not yet initiated antiretroviral treatment (ART) is poorly understood in Africa. We describe severe morbidity and mortality of untreated HIV-infected children...
  75. ncbi request reprint Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998
    C Marimoutou
    , , 146 rue Leo Saignat, 33076 Bordeaux, France
    J Acquir Immune Defic Syndr 27:161-7. 2001
    ..Based on our results, a high baseline HIV-RNA level is associated with isolated immunologic response; moreover, age should be of importance in treatment decision...
  76. ncbi request reprint Incidence and risk factors of severe hypertriglyceridaemia in the era of highly active antiretroviral therapy: the Aquitaine Cohort, France, 1996-99
    R Thiebaut
    Unité INSERM 330, Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    HIV Med 2:84-8. 2001
    ..To estimate the incidence of serum hypertriglyceridaemia > 6 mm/L (HTG) and identify associated factors in the era of highly active antiretroviral therapy (HAART)...
  77. doi request reprint All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration
    Charlotte Lewden
    INSERM, U897, ISPED, Université Bordeaux Segalen, Bordeaux, France
    Int J Epidemiol 41:433-45. 2012
    ..Using data from a large European collaborative study, we aimed to identify the circumstances in which treated HIV-infected individuals will experience similar mortality rates to those of the general population...
  78. pmc Couple-oriented prenatal HIV counseling for HIV primary prevention: an acceptability study
    Joanna Orne-Gliemann
    Institut de Santé Publique Epidémiologie Développement ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    BMC Public Health 10:197. 2010
    ....
  79. ncbi request reprint HIV-1/AIDS and maternal and child health in Africa
    Francois Dabis
    INSERM U 330, ISPED, Universite Victor Segalen, Bordeaux, France
    Lancet 359:2097-104. 2002
    ..Prevention of mother-to-child transmission should become a universal standard of care in Africa, and research should continue to reduce the transmission risk to well below 5%...
  80. doi request reprint Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study
    Linda Wittkop
    INSERM U897 Centre of Epidemiology and Biostatistics, ISPED Bordeaux School of Public Health, University Bordeaux Segalen, Bordeaux, France
    Lancet Infect Dis 11:363-71. 2011
    ..We investigated the effect of TDR on outcome in the first year of cART within a large European collaboration...
  81. doi request reprint [Survival, clinical and biological outcomes of HIV-infected children treated by antiretroviral therapy in Africa: systematic review, 2004-2009]
    Camille Ndondoki
    Universite Victor Segalen Bordeaux 2, Institut de Santé Publique, d Epidémiologie et de Développement ISPED, 33076 Bordeaux, France
    Presse Med 40:e338-57. 2011
    ..This paper aims to review the effectiveness of cotrimoxole prophylaxis and antiretroviral treatment in HIV-infected children in Africa, specifically mortality and treatment outcomes...
  82. ncbi request reprint Implementing a rural programme of prevention of mother-to-child transmission of HIV in Zimbabwe: first 18 months of experience
    Freddy Perez
    Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen, Bordeaux, France
    Trop Med Int Health 9:774-83. 2004
    ..To report on activities and lessons learned during the first 18 months of a rural programme of prevention of mother-to-child transmission of HIV (PMTCT) in Zimbabwe...
  83. ncbi request reprint Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004
    F Bonnet
    CHU de Bordeaux, Services de Médecine Interne et Maladies Infectieuses, Bordeaux, France
    HIV Med 8:547-54. 2007
    ..The aim of the study was to characterize the causes, trends and determinants of severe morbidity in a large cohort of HIV-infected patients between 2000 and 2004...
  84. ncbi request reprint Effect of early chemoprophylaxis with co-trimoxazole on nutritional status evolution in HIV-1-infected adults in Abidjan, Côte d'Ivoire
    K Castetbon
    INSERM U.330, , Bordeaux, France
    AIDS 15:869-76. 2001
    ....
  85. ncbi request reprint Predictors of hypertension and changes of blood pressure in HIV-infected patients
    Rodolphe Thiebaut
    INSERM E0338 epsilont U593, ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    Antivir Ther 10:811-23. 2005
    ..We assessed predictors of changes in systolic (SBP) and diastolic (DBP) blood pressure during follow-up and of the development of hypertension in HIV-infected individuals...
  86. pmc Participation of traditional birth attendants in prevention of mother-to-child transmission of HIV services in two rural districts in Zimbabwe: a feasibility study
    Freddy Perez
    Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, France
    BMC Public Health 8:401. 2008
    ..The main objective was to evaluate acceptability and feasibility of reinforcing the role of traditional birth attendants (TBAs) in family and child health services through their participation in PMTCT programmes in Zimbabwe...
  87. ncbi request reprint Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort
    Antoine Benard
    INSERM, U593, Universite Victor Segalen Bordeaux 2, ISPED, F 33076 Bordeaux, France
    AIDS Patient Care STDS 21:458-68. 2007
    ..To be successful, smoking cessation interventions should be specifically built to take into account depression and codependencies in addition to nicotine dependence and motivation...
  88. ncbi request reprint HIV prevention in Latin America: reaching youth in Colombia
    F Perez
    Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, 146, rue Leo Saignat, 33076 Bordeaux, France
    AIDS Care 15:77-87. 2003
    ....
  89. ncbi request reprint Community-based assessment of infant feeding practices within a programme for prevention of mother-to-child HIV transmission in rural Zimbabwe
    J Orne-Gliemann
    ISPED Zimbabwe, 33 Lawson Avenue, Milton Park, Harare, Zimbabwe
    Public Health Nutr 9:563-9. 2006
    ..To describe the infant feeding practices and attitudes of women who used prevention of mother-to-child transmission of HIV (PMTCT) services in rural Zimbabwe...
  90. ncbi request reprint A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999
    F Bonnet
    Fédération de médecine interne, Maladies Infectieuses et Pathologies Tropicales, Hôpital Saint André, Centre Hospitalier Universitaire de Bordeaux, Universite Victor Segalen, Bordeaux, France
    Clin Infect Dis 35:1231-7. 2002
    ..Coinfection with HCV or HBV increased the risk of hepatotoxicity, which lead to the cautious use of nevirapine for such patients...
  91. ncbi request reprint [Transmission of tuberculosis in Gironde: epidemiologic investigation by genomic analysis of Mycobacterium tuberculosis]
    S Elia-Pasquet
    Réseau Tuberculose Gironde RTG, Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen, Bordeaux, France
    Rev Epidemiol Sante Publique 48:127-36. 2000
    ..The aim of this study is to identify, in a French department, the proportion of clustering cases of tuberculosis, suspected of recent contamination...
  92. ncbi request reprint [Reduction of mother-child transmission of HIV infection in Africa: from clinical research to public health programs]
    V Leroy
    L Unité INSERM 330, Université Victor Segalen Bordeaux II, France
    Med Trop (Mars) 59:456-64. 1999
    ..Management of HIV-infected children must remain a high priority. Implementation of currently available strategies is now under discussion...
  93. ncbi request reprint Prognostic value of cross-sectional anthropometric indices on short-term risk of mortality in human immunodeficiency virus-infected adults in Abidjan, Côte d'Ivoire
    K Castetbon
    INSERM U 330, Universite Victor Segalen Bordeaux 2, 146 rue de Léo Saignat, 33076 Bordeaux Cedex, France
    Am J Epidemiol 154:75-84. 2001
    ..In Côte d'Ivoire where chemoprophylaxis of opportunistic infections has recently been recommended to be widely initiated on clinical criteria, such thresholds may help to screen patients with higher risks of mortality...
  94. ncbi request reprint Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000
    F Dabis
    Unité INSERM no 330, Universite Victor Segalen Bordeaux, France
    AIDS 14:1017-26. 2000
    ..New findings from these trials are now becoming available, the implications of which, for population-based intervention programmes, need urgent consideration...
  95. ncbi request reprint Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997
    S Vandentorren
    INSERM U330, , France
    Eur J Epidemiol 17:7-10. 2001
    ..7% to 72.2% (p = 0.007). CONCLUSION: HAART treatment has reduced the number and percentage of deaths due to AIDS-related causes among persons who died with HIV infection in South-western France...
  96. ncbi request reprint Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997
    C Binquet
    , , , France
    Am J Epidemiol 153:386-93. 2001
    ..The findings support the potential for interruption of certain types of prophylaxis against opportunistic infections under reasonable conditions of duration of antiretroviral therapy and sustained CD4+ cell response...
  97. pmc Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries
    A Jaquet
    HIV Epidemiology, Institut National de la Sante et de la Recherche Medicale CRE U 897, Universite Victor Segalen, Bordeaux, France
    Int J Tuberc Lung Dis 13:1433-9. 2009
    ..Tobacco smoking is common in human immunodeficiency virus (HIV) infected patients from industrialised countries. In West Africa, few data concerning tobacco consumption exist...
  98. ncbi request reprint International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV
    V Leroy
    Unité INSERM 330, Universite Victor Segalen Bordeaux 2, France
    Lancet 352:597-600. 1998
    ..We aimed to estimate the rate and timing of late postnatal transmission of HIV-1...
  99. ncbi request reprint Determinants of smoking cessation attempts among HIV-infected patients results from a hospital-based prospective cohort
    Gaelle Encrenaz
    INSERM, U897, CIC EC7, Bordeaux, F 33076 France
    Curr HIV Res 8:212-7. 2010
    ..Tobacco smoking is a major modifiable risk factor of these emergent conditions and almost half of these patients are regular smokers in resource-rich countries...
  100. ncbi request reprint Determinants of response to first HAART regimen in antiretroviral-naïve patients with an estimated time since HIV seroconversion
    R Thiebaut
    INSERM E0338 Biostatistics, Bordeaux 2 University, Bordeaux, France
    HIV Med 7:1-9. 2006
    ..To study the determinants of immunological and virological response to highly active antiretroviral therapy (HAART) in naïve patients, adjusting for time since HIV-1 seroconversion...
  101. ncbi request reprint 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group.
    F Dabis
    Unité INSERM 330, Universite Victor Segalen Bordeaux 2, France
    Lancet 353:786-92. 1999
    ..Zidovudine reduces the rate of vertical transmission of HIV in non-breastfed populations. We assessed the acceptability, tolerance, and 6-month efficacy of a short regimen of oral zidovudine in African populations practising breastfeeding...

Research Grants2

  1. WADA (West Africa Database on Antiretroviral Therapy) Collaboration
    Francois Dabis; Fiscal Year: 2007
    ..This university team (Prof Francois Dabis, ISPED, Universite Victor Segalen) has a long lasting experience in epidemiological HIV cohort research in ..